HARBIN, China--(BUSINESS WIRE)--Renhuang Pharmaceuticals, Inc. (or “the Company”, Stock symbol: RHGP.OB), a leading provider of natural health care products in the People’s Republic of China (PRC), today announced that its seventh R&D project has been included into the Spark Program sponsored by the Ministry of Science and Technology of the People’s republic of China.
